Frederick Wasinski

Prof. Dr. Frederick Wasinski


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TFThaina Maquedo Franco
Thaina Maquedo Franco
MTMariana Rosolen Tavares
Mariana Rosolen Tavares
LNLeonardo Santana Novaes
Leonardo Santana Novaes
CMCarolina Munhoz
Carolina Munhoz
JPJose Eduardo Peixoto-Santos
Jose Eduardo Peixoto-Santos
FWFrederick Wasinski
Frederick Wasinski
The kallikrein–kinin system is a versatile regulatory network implicated in various biological processes encompassing inflammation, nociception, blood pressure control, and central nervous system functions. Its physiological impact is mediated through G-protein-coupled transmembrane receptors, specifically the B1 and B2 receptors. Dopamine, a key catecholamine neurotransmitter widely distributed in the CNS, plays a crucial role in diverse physiological functions including motricity, reward, anxiety, fear, feeding, sleep, and arousal. Notably, the potential physical interaction between bradykinin and dopaminergic receptors has been previously documented. In this study, we aimed to explore whether B2R modulation in catecholaminergic neurons influences the dopaminergic pathway, impacting behavioral, metabolic, and motor aspects in both male and female mice. B2R ablation in tyrosine hydroxylase cells reduced the body weight and lean mass without affecting body adiposity, substrate oxidation, locomotor activity, glucose tolerance, or insulin sensitivity in mice. Moreover, a B2R deficiency in TH cells did not alter anxiety levels, exercise performance, or motor coordination in female and male mice. The concentrations of monoamines and their metabolites in the substantia nigra and cortex region were not affected in knockout mice. In essence, B2R deletion in TH cells selectively influenced the body weight and composition, leaving the behavioral and motor aspects largely unaffected.

29 January 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
MTMariana R. Tavares
Mariana R. Tavares
GEGabriel R. Estrela
Gabriel R. Estrela
LLLuana Lavezo
Luana Lavezo
JSJuliene L. S. Silva
Juliene L. S. Silva
RARonaldo C. Araujo
Ronaldo C. Araujo
FWFrederick Wasinski
Frederick Wasinski
The kallikrein–kinin system (KKS) plays a key role in inflammatory responses, but its specific contribution to neuroinflammation remains to be fully elucidated. The bradykinin B 2 receptor (B 2 R), a principal effector of the KKS, is widely expressed in both neuronal and glial cells in the rodent and human brain. In this study, we investigated the molecular contribution of B 2 R to neuroinflammation using complementary in vitro and in vivo models. Lipopolysaccharide (LPS) stimulation significantly upregulated B 2 R mRNA expression in primary astrocyte cultures and in the cortical tissue of wild-type mice. Pharmacological blockade of B 2 R in astrocytes markedly suppressed the LPS-induced proinflammatory gene expression. In contrast, B 2 R antagonism in vivo resulted in only partial attenuation of the neuroinflammatory response. Together, these findings suggest cell type–specific roles for B 2 R and underscore its key contribution to astrocyte-mediated neuroinflammation. Graphical Abstract B 2 R antagonism highlights cell type–specific roles in neuroinflammation. B 2 R pharmacological antagonism suppresses proinflammatory gene expression in astrocytes but shows limited in vivo efficacy, indicating differential functions across brain cell types.

23 May 2026 in Molecules
Verified
Journal Article
Open access
PDF file
KMKételin Vitória Matias
Kételin Vitória Matias
Mario Augusto IzidoroMario Augusto Izidoro
Mario Augusto Izidoro
FJFernando Barbosa Jr
Fernando Barbosa Jr
BRBruno Alves Rocha
Bruno Alves Rocha
VFVictor Silva Fonseca
Victor Silva Fonseca
CSCarla Scorza
Carla Scorza
Parkinson’s disease (PD) is characterized by progressive nigrostriatal degeneration and striatal dysfunction, yet its metabolic remodeling remains incompletely defined. Here, untargeted GC–MS metabolomics was used to investigate the effects of standardized Brazilian green propolis on the striatal metabolic profile in the 6-hydroxydopamine (6-OHDA) rat model. Discriminant metabolites, including suberic acid, gluconic acid, heptadecane, and tartaric acid, distinguished experimental groups, capturing key features of the metabolic response to dopaminergic injury and treatment. Suberic acid emerged as a prominently modulated metabolite, potentially linked to alterations in lipid catabolism associated with mitochondrial–peroxisomal pathways. Propolis treatment attenuated the elevation of suberic acid, accompanied by a reduction in gluconic acid levels, suggesting a metabolic profile linked to pathways involved in redox balance and glucose handling. Given previous reports identifying heptadecane as a hydrocarbon constituent of volatile propolis fractions, complementary GC-Q-TOF analyses demonstrated that heptadecane was absent from the administered extract, despite its consistent association with propolis-treated groups. Metabolic changes were accompanied by attenuation of nigrostriatal dopaminergic neurodegeneration and improved motor performance. Together, these findings delineate a striatal metabolic signature associated with Brazilian green propolis and identify suberic acid as a key metabolite linked to neuroprotection in experimental Parkinsonism.

13 May 2026 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
JSJuliene L. S. Silva
Juliene L. S. Silva
MTMariana R. Tavares
Mariana R. Tavares
LLLuana Lavezo
Luana Lavezo
FWFrederick Wasinski
Frederick Wasinski
The kallikrein–kinin system (KKS) is a proteolytic signaling pathway traditionally associated with vascular regulation and inflammation, but increasing evidence indicates that its components are also expressed in the central nervous system. The bradykinin B2 receptor (B2R), the main mediator of kinin signaling, has been implicated in neuronal differentiation, synaptic modulation, and activity-dependent neuroplasticity. However, its physiological role in neural circuit regulation remains poorly understood. Recent studies using cell-type–specific genetic models suggest that neuronal B2R signaling is largely dispensable for maintaining basal behavioral states. In contrast, growing evidence indicates that B2R plays a more prominent role in glial-mediated inflammatory responses, particularly in astrocytes. Here, we propose that B2R functions as a context-dependent neuromodulatory system that links neuroinflammatory signaling to neural circuit plasticity. Within this framework, B2R activation may become functionally relevant during inflammatory conditions or physiological stimulation, influencing dopaminergic circuits involved in motivation and reward-related behaviors.